StockData
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU

Drugs Made In America Acquisition II Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.18−0.00 (-0.05%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Drugs Made In America Acquisition II has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Drugs Made In America Acquisition II filed with the SEC